Autonomic Modulation in Heart Failure: Ready for Prime Time?

Mark E. Dunlap, Anju Bhardwaj, Paul Hauptman

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

It has been known for many decades that multiple abnormalities of the autonomic nervous system (ANS) are present in heart failure (HF). Moreover, many of the effective therapies currently used to treat HF have either direct or indirect effects on the ANS. While therapies that block over-activity of the sympathetic nervous system are now standard of care, much less well studied are therapies aimed at augmenting the parasympathetic nervous system. This review will cover recent and ongoing investigations targeting modulation of the ANS, especially highlighting new and ongoing studies directed toward augmenting parasympathetic mechanisms.

Original languageEnglish (US)
Article number103
JournalCurrent Cardiology Reports
Volume17
Issue number11
DOIs
StatePublished - Nov 25 2015
Externally publishedYes

Fingerprint

Autonomic Nervous System
Heart Failure
Parasympathetic Nervous System
Multiple Abnormalities
Sympathetic Nervous System
Standard of Care
Therapeutics

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Autonomic Modulation in Heart Failure : Ready for Prime Time? / Dunlap, Mark E.; Bhardwaj, Anju; Hauptman, Paul.

In: Current Cardiology Reports, Vol. 17, No. 11, 103, 25.11.2015.

Research output: Contribution to journalReview article

@article{3299c1fab3284d63a77802125051c2e3,
title = "Autonomic Modulation in Heart Failure: Ready for Prime Time?",
abstract = "It has been known for many decades that multiple abnormalities of the autonomic nervous system (ANS) are present in heart failure (HF). Moreover, many of the effective therapies currently used to treat HF have either direct or indirect effects on the ANS. While therapies that block over-activity of the sympathetic nervous system are now standard of care, much less well studied are therapies aimed at augmenting the parasympathetic nervous system. This review will cover recent and ongoing investigations targeting modulation of the ANS, especially highlighting new and ongoing studies directed toward augmenting parasympathetic mechanisms.",
author = "Dunlap, {Mark E.} and Anju Bhardwaj and Paul Hauptman",
year = "2015",
month = "11",
day = "25",
doi = "10.1007/s11886-015-0652-2",
language = "English (US)",
volume = "17",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "11",

}

TY - JOUR

T1 - Autonomic Modulation in Heart Failure

T2 - Ready for Prime Time?

AU - Dunlap, Mark E.

AU - Bhardwaj, Anju

AU - Hauptman, Paul

PY - 2015/11/25

Y1 - 2015/11/25

N2 - It has been known for many decades that multiple abnormalities of the autonomic nervous system (ANS) are present in heart failure (HF). Moreover, many of the effective therapies currently used to treat HF have either direct or indirect effects on the ANS. While therapies that block over-activity of the sympathetic nervous system are now standard of care, much less well studied are therapies aimed at augmenting the parasympathetic nervous system. This review will cover recent and ongoing investigations targeting modulation of the ANS, especially highlighting new and ongoing studies directed toward augmenting parasympathetic mechanisms.

AB - It has been known for many decades that multiple abnormalities of the autonomic nervous system (ANS) are present in heart failure (HF). Moreover, many of the effective therapies currently used to treat HF have either direct or indirect effects on the ANS. While therapies that block over-activity of the sympathetic nervous system are now standard of care, much less well studied are therapies aimed at augmenting the parasympathetic nervous system. This review will cover recent and ongoing investigations targeting modulation of the ANS, especially highlighting new and ongoing studies directed toward augmenting parasympathetic mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=84942233285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942233285&partnerID=8YFLogxK

U2 - 10.1007/s11886-015-0652-2

DO - 10.1007/s11886-015-0652-2

M3 - Review article

C2 - 26384110

AN - SCOPUS:84942233285

VL - 17

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 11

M1 - 103

ER -